Texas Halo Fund, established in 2012 and headquartered in Houston, Texas, is an investment company that focuses on early-stage venture capital. It manages multiple funds, each with a distinct investment focus, including healthcare, information technology, software, life science, and consumer products. The firm seeks compelling investment opportunities across various industries and geographies, aiming to generate high returns with low risk for its investors. It typically invests in 20-25 companies per fund, with an investment horizon of 5 to 7 years.
Managing Director and Fund I Deal Committee Member
Bill Wheelock
Managing Director
88 past transactions
Flourish Collective
Convertible Note in 2022
Flourish Collective is a digital platform designed to support new and expecting families by enhancing access to maternal healthcare and wellness services. It features a marketplace that offers evidence-based products and vetted maternal wellness services, along with a funding mechanism that allows friends and family to contribute towards a positive birth and parenting experience. By providing resources for pregnancy, birth, and postpartum care, Flourish Collective aims to bridge gaps in maternal healthcare, making essential wellness services accessible to all mothers from pregnancy through motherhood.
Vartega
Seed Round in 2022
Vartega Inc. specializes in recycling carbon fiber, a material known for its strength and lightweight properties, primarily serving the aerospace, automotive, wind energy, and sporting goods sectors. Founded in 2014 and based in Golden, Colorado, Vartega has developed a patented recycling process that produces low-cost carbon fiber suitable for various applications, including thermoplastic pellets, nonwoven fabrics, yarns, and three-dimensional printing filament. The company’s technology effectively diverts carbon fiber scrap and waste from landfills, contributing to environmental sustainability by reducing greenhouse gas emissions and enhancing fuel economy in vehicles. Vartega's carbon fiber is available in multiple forms, including semi-continuous, chopped, and milled, making it adaptable for mass-market use.
Drusolv Therapeutics
Convertible Note in 2022
Drusolv Therapeutics is a clinical-stage drug company focused on developing a novel high-dose statin, known as ocustatin, for early intervention in age-related macular degeneration (AMD). This treatment targets patients in the intermediate stage of the disease, who currently face limited options to prevent progression to late-stage vision loss. Ocustatin, developed at Harvard University, has demonstrated promising results in a successful proof-of-concept clinical trial, which showed a 75% reduction in the progression to late-stage blindness. The company's mission is to provide doctors with effective tools to treat AMD and improve patient outcomes.
Rellevate
Seed Round in 2022
Rellevate, LLC is a financial services company based in Stamford, Connecticut, established in 2019. It specializes in digital banking services designed to enhance consumer financial management. Rellevate offers a range of products, including digital accounts that earn interest, as well as features like Pay Any-Day, bill payment, and money transfer services. These offerings are primarily delivered through employers, aiming to improve employee retention, satisfaction, and loyalty. By allowing users to access, move, and utilize their money anytime and anywhere, Rellevate empowers consumers to take greater control of their finances and fosters a more adaptable financial ecosystem.
Dynamic Light
Convertible Note in 2022
Dynamic Light, established in May 2018 and based in Austin, Texas, specializes in advanced blood flow imaging technology aimed at enhancing patient care and reducing healthcare costs. The company’s innovative solution enables real-time, continuous, and quantitative visualization of blood flow in living tissues, allowing surgeons to make informed decisions during procedures. By providing high-resolution imaging without the need for dyes or procedural interruptions, Dynamic Light's technology supports improved surgical outcomes and patient management.
Sonnest
Convertible Note in 2022
Sonnest is a clinical healthcare company focused on myocardium-related solutions. It specializes in developing an electrically sensitive imaging agent that assesses and monitors the heart's perfusion, structure, and function. This innovative agent activates through ultrasound and responds to the heart's local electric field, indicating the viability of heart tissue. By providing advanced imaging technology, Sonnest aims to enhance patient care and clinical outcomes. The company addresses customer inquiries through various channels, including phone, email, and online applications, ensuring comprehensive support for healthcare professionals.
Global Neighbor
Seed Round in 2021
Global Neighbor specializes in developing environmentally friendly directed energy solutions for weed control, specifically targeting herbicide-resistant weeds in agriculture. Their flagship product, the Weed Seed Destroyer (WDSD), is designed to attach to combine harvesters, utilizing high-intensity light to render weed seeds non-viable during the harvesting process. This innovative approach eliminates the need for harmful herbicides, promoting sustainable agricultural practices while maximizing farm profitability. Global Neighbor aims to facilitate the adoption of these non-chemical solutions among consumers, who can access their directed energy products through online platforms and big-box retailers. By addressing the challenges posed by resistant weed species, Global Neighbor offers a clear and effective alternative for modern farming.
Vartega
Series A in 2021
Vartega Inc. specializes in recycling carbon fiber, a material known for its strength and lightweight properties, primarily serving the aerospace, automotive, wind energy, and sporting goods sectors. Founded in 2014 and based in Golden, Colorado, Vartega has developed a patented recycling process that produces low-cost carbon fiber suitable for various applications, including thermoplastic pellets, nonwoven fabrics, yarns, and three-dimensional printing filament. The company’s technology effectively diverts carbon fiber scrap and waste from landfills, contributing to environmental sustainability by reducing greenhouse gas emissions and enhancing fuel economy in vehicles. Vartega's carbon fiber is available in multiple forms, including semi-continuous, chopped, and milled, making it adaptable for mass-market use.
Rx Bandz
Convertible Note in 2021
Rx Bandz specializes in the development of advanced auto-injectors designed to deliver a variety of injectable medications for active patients. Their innovative devices are tailored to address urgent medical needs, including anaphylaxis, pain management, diabetes, and opioid overdose, as well as the administration of vaccines and biologics. The auto-injectors are engineered to be highly reliable and waterproof, enhancing accessibility for patients, medics, and first responders who may need to carry emergency self-injectable medications. The company is focused on both device and formulation development, aiming to improve the delivery methods for critical medications in various healthcare scenarios.
WorkEQ
Seed Round in 2021
WorkEQ is a business development and employment agency that focuses on enhancing workplace dynamics through flexible and productive work-life balance solutions. The company has developed a platform for contact tracing and health monitoring, designed to protect individuals from infectious diseases. This platform enables organizations to quickly access data on symptom onset and identify potentially exposed employees, facilitating timely responses to prevent viral outbreaks. By prioritizing health and safety, WorkEQ aims to improve employee engagement and productivity while fostering a more flexible and inclusive work environment.
Kegg
Seed Round in 2021
Kegg is a fertility tracking device that combines the functions of monitoring vaginal fluid and facilitating pelvic floor exercises. Founded in 2017 and based in San Francisco, California, Kegg utilizes advanced sensing technology to detect changes in cervical fluid, thereby enabling women to identify their fertile window and ovulation up to seven days in advance. This innovative approach provides essential data that enhances the diagnosis, monitoring, and treatment of women's reproductive health, significantly increasing the chances of natural conception. By offering an intuitive and effective solution, Kegg empowers women with the information they need to make informed decisions regarding their fertility.
Work & Mother
Convertible Note in 2021
Work & Mother is a provider of lactation room services designed to support working mothers in achieving a better work-life balance. The company offers a network of fully equipped lactation suites located in commercial office buildings, providing essential amenities such as hospital-grade pumping equipment, refrigeration, and cleaning facilities. This setup allows employers to meet legal requirements for providing mothers' rooms, while also enhancing workplace wellness initiatives. Additionally, Work & Mother features a support app that offers resources to assist mothers in their breastfeeding journeys, ensuring they can maintain their breastfeeding goals with privacy and safety after returning to work. This comprehensive approach addresses the needs of working mothers, contributing to their well-being and that of their children.
Ictero Medical
Convertible Note in 2021
Ictero Medical is a medical device company focused on developing minimally invasive solutions for gallbladder ablation. The company offers a specialized tool designed to treat high-risk patients suffering from gallstone disease. This innovative treatment can be performed in an interventional radiology suite, requiring only minimal local anesthesia. By defunctionalizing the gallbladder without surgical removal, Ictero Medical enables physicians to provide patients with the advantages of surgical intervention while significantly reducing associated risks.
Path Ex
Convertible Note in 2021
Path Ex, Inc. is a Nashville-based company established in 2017 that specializes in the development of extracorporeal blood-cleansing equipment aimed at treating sepsis, a severe and often fatal condition linked to blood-borne infections. The company has created a proprietary technology that selectively separates and captures bacteria and toxins from human blood, offering a novel approach to treatment. Unlike traditional methods that rely on broad-spectrum antibiotics to kill infections, Path Ex's device effectively removes intact bacteria from the bloodstream, regardless of the bacteria type or antibiotic resistance. This innovative technology has the potential to improve patient outcomes by reducing diagnostic times, treatment costs, readmission rates, and fatalities associated with sepsis.
Galen Data
Series A in 2021
Galen Data, Inc. is a healthcare technology company based in Houston, Texas, founded in 2016. It offers a cloud-based software platform designed for medical devices, enabling them to centralize and securely store data while leveraging cloud technologies. The platform is FDA-compliant and HITRUST-certified, integrating seamlessly with major electronic health record systems. Galen Data provides tools for data visualization and analytics, which help healthcare providers track patient compliance and optimize information management. By maintaining the necessary infrastructure and ensuring compliance with cybersecurity and global regulations, the company allows medical device companies to focus on their core innovations without needing expertise in software design or data management. This approach offers significant time and cost savings, as well as reduced risk in bringing medical devices to market.
Machfu
Series A in 2021
Machfu Inc. is a company that specializes in applications and infrastructure for the industrial Internet of Things (IoT), facilitating data, analytics, and visualization for industrial enterprises. Based in Rockville, Maryland, Machfu has developed a smartphone for machines that enhances communication between industrial assets and integrates them with both legacy systems and cloud-based platforms. The company's Mach-IT solution enables seamless communication among various pieces of equipment and information processing systems. Founded in 2015, Machfu aims to simplify the management of industrial IoT environments, providing real-time visibility into operations and equipping operators with the data needed to make informed decisions. This focus on ease of use allows companies to effectively manage their IIoT ecosystems, encompassing hardware, networking, and security.
Materna Medical
Series A in 2021
Materna Medical, Inc. is a medical device company based in Mountain View, California, focused on developing innovative solutions to reduce childbirth-related injuries during vaginal delivery. Incorporated in 2010, the company addresses significant unmet needs in women's pelvic health, operating within a $6 billion market. Materna Medical combines expertise from a diverse team of engineers, scientists, and commercial leaders to transform the standard of care in obstetrics and gynecology. The company's mission centers on empowering women to safeguard their pelvic health through advanced medical technology.
Work & Mother
Pre Seed Round in 2021
Work & Mother is a provider of lactation room services designed to support working mothers in achieving a better work-life balance. The company offers a network of fully equipped lactation suites located in commercial office buildings, providing essential amenities such as hospital-grade pumping equipment, refrigeration, and cleaning facilities. This setup allows employers to meet legal requirements for providing mothers' rooms, while also enhancing workplace wellness initiatives. Additionally, Work & Mother features a support app that offers resources to assist mothers in their breastfeeding journeys, ensuring they can maintain their breastfeeding goals with privacy and safety after returning to work. This comprehensive approach addresses the needs of working mothers, contributing to their well-being and that of their children.
Ikonopedia
Series D in 2021
Ikonopedia, LLC specializes in developing a cloud-based breast study interpretation and reporting system aimed at enhancing the workflows of radiologists. Established in 2012 and headquartered in Dallas, Texas, the company provides a comprehensive Mammography Reporting System that generates structured, MQSA-compliant reports tailored to individual radiologists, as well as SonoPro, a web application designed to assist radiologists during diagnostic breast ultrasound exams. Ikonopedia's solutions are utilized in telemammography and satellite clinics, featuring capabilities such as automated patient tracking and monitoring to ensure comprehensive care. The system supports patient letters and questionnaires in multiple languages and is designed to be compatible with modern devices. By prioritizing clear and consistent clinical reporting, Ikonopedia aims to enhance patient safety, reduce errors, and ensure compliance with industry standards, ultimately contributing to improved health outcomes for women.
Sonnest
Series A in 2021
Sonnest is a clinical healthcare company focused on myocardium-related solutions. It specializes in developing an electrically sensitive imaging agent that assesses and monitors the heart's perfusion, structure, and function. This innovative agent activates through ultrasound and responds to the heart's local electric field, indicating the viability of heart tissue. By providing advanced imaging technology, Sonnest aims to enhance patient care and clinical outcomes. The company addresses customer inquiries through various channels, including phone, email, and online applications, ensuring comprehensive support for healthcare professionals.
CellChorus
Convertible Note in 2021
CellChorus specializes in advanced single-cell analysis for biopharmaceutical companies, utilizing its proprietary TIMING™ platform. This visual artificial intelligence technology enables dynamic evaluation of cell activation, killing, and movement over time. By integrating data on kinetics and interactions with insights from single-cell RNA sequencing and flow cytometry, CellChorus provides healthcare organizations with a comprehensive understanding of cellular function, state, and phenotype. This innovative approach aims to enhance the development and efficacy of immuno-oncology therapies and other medical treatments.
VenoStent
Seed Round in 2021
VenoStent, Inc. is a clinical-stage tissue engineering company based in Nashville, Tennessee, with an additional office in Houston, Texas. Founded in 2017, it specializes in the development of bioresorbable smart polymers designed to enhance vascular surgery outcomes. The company’s primary product, SelfWrap, is a perivascular wrap that functions as an external stent, providing mechanical support to veins and promoting outward growth. This innovative technology aims to reduce complications at the vein-artery junction in dialysis patients, particularly by minimizing vein collapse and improving the usability of arteriovenous fistulas (AVF). By utilizing a new class of shape-memory polymers that do not require sutures, VenoStent's approach reduces surgery time and lowers the risk of infection, ultimately enhancing the quality and length of life for patients with chronic kidney disease undergoing hemodialysis.
Allotrope Medical
Series A in 2021
Allotrope Medical Inc. is a Houston-based medical device company focused on enhancing surgical procedures by developing innovative devices for ureter identification. The company's flagship product, the StimSite, is an intuitive handheld device that aids surgeons in quickly and accurately locating ureters during pelvic surgeries. This device features a simple design with a single button, eliminating the need for complex pre- and post-operative procedures. Founded in 2016, Allotrope Medical aims to improve surgical outcomes by providing tools that streamline the identification and localization of ureters, thus facilitating safer and more efficient operations.
Your Fare
Convertible Note in 2021
Your Fare, Inc., established in 2016 and based in San Francisco, California, specializes in developing an application that enables restaurants to manage all their online orders through a single platform. The company's ordering management system allows restaurateurs to consolidate orders from various sources, replace traditional online ordering tablets, and monitor daily sales via one dashboard. Additionally, Your Fare helps manage third-party delivery services, integrating them into a unified interface. This streamlined approach aims to enhance operational efficiencies and profit margins for restaurants by automating the handling of online meal orders and reducing order delivery time.
Chosen Diagnostics
Convertible Note in 2020
Chosen Diagnostics specializes in developing innovative biomarker diagnostic kits aimed at enhancing healthcare delivery for neonates. The company’s primary product is a test designed to diagnose a serious and potentially life-threatening bowel disease in preterm infants. This diagnostic kit provides more accurate results compared to existing methods, facilitating earlier medical intervention. By enabling timely detection of critical health issues, Chosen Diagnostics aims to improve treatment outcomes for thousands of low birth weight preterm infants, ultimately leading to better healthcare results in this vulnerable population.
Kegg
Convertible Note in 2020
Kegg is a fertility tracking device that combines the functions of monitoring vaginal fluid and facilitating pelvic floor exercises. Founded in 2017 and based in San Francisco, California, Kegg utilizes advanced sensing technology to detect changes in cervical fluid, thereby enabling women to identify their fertile window and ovulation up to seven days in advance. This innovative approach provides essential data that enhances the diagnosis, monitoring, and treatment of women's reproductive health, significantly increasing the chances of natural conception. By offering an intuitive and effective solution, Kegg empowers women with the information they need to make informed decisions regarding their fertility.
Connectus Global
Seed Round in 2020
ConnectUs Global specializes in real-time location tracking and electronic permitting solutions aimed at enhancing geospatial intelligence across various environments, including buildings, airports, and manufacturing facilities. The company offers a dual frequency UWB solution, along with Wi-Fi-based badges, tags, and receivers that provide precise position data. This technology allows organizations to monitor assets and personnel effectively, improving production efficiency, streamlining inventory processes, and enhancing employee safety. By integrating sensors and detailed building information, ConnectUs Global enables clients to optimize their operational capabilities in diverse sectors.
ImmunoGenes
Series A in 2020
ImmunoGenes is a biotech company focused on the development of monoclonal antibodies using its proprietary platform technology that enhances immune responses through genetically-modified mice and rabbits overexpressing the neonatal Fc receptor. This patented IMG-AbS technology generates a higher quantity and diversity of B cell clones, facilitating robust immune responses to weakly immunogenic targets. As a result, ImmunoGenes produces high-quality monoclonal antibody candidates characterized by strong affinity and diversity, which pharmaceutical and biotech companies can leverage for the development of innovative therapeutics and diagnostics. The company collaborates with various partners, including pharmaceutical firms, academic institutions, and research organizations, to discover and develop antibody drugs aimed at challenging and novel targets, while also offering services such as custom antibody development and advisory support to enhance the efficiency of therapeutic target identification.
ImmunoGenesis
Venture Round in 2020
ImmunoGenesis is focused on developing innovative immune therapies aimed at treating tumors that exhibit low levels of activated T cells or other immune resistance mechanisms. The company specializes in creating immuno-oncology therapeutics designed to effectively address cold tumors, particularly in challenging cancers such as prostate, colorectal, and pancreatic cancer. By targeting key mechanisms of immune resistance, ImmunoGenesis aims to enhance immune responses and provide healthcare professionals with advanced treatment options for cancer patients.
TrueSpot
Seed Round in 2020
TrueSpot is a leader in geo-intelligent operations, specializing in high-fidelity real-time location services and asset mapping for various industries. The company offers a platform that enables organizations to track and locate assets both on-campus and off-campus, transforming location data into actionable geo-intelligence. This geo-intelligence combines real-time location with a comprehensive understanding of operations and workflows. In the retail automotive sector, TrueSpot's solutions include Lot Management 360, TrueRecon, and Fixed Ops 360, which enhance inventory management and streamline the auto-reconditioning process. In the healthcare industry, the company provides MedSpot360, further showcasing its versatility in applying location-based technology to improve operational efficiency.
Kegg
Seed Round in 2020
Kegg is a fertility tracking device that combines the functions of monitoring vaginal fluid and facilitating pelvic floor exercises. Founded in 2017 and based in San Francisco, California, Kegg utilizes advanced sensing technology to detect changes in cervical fluid, thereby enabling women to identify their fertile window and ovulation up to seven days in advance. This innovative approach provides essential data that enhances the diagnosis, monitoring, and treatment of women's reproductive health, significantly increasing the chances of natural conception. By offering an intuitive and effective solution, Kegg empowers women with the information they need to make informed decisions regarding their fertility.
PyrAmes
Seed Round in 2020
PyrAmes is a healthcare technology company focused on transforming the delivery of medical care through advanced sensor measurement. The company has developed a paper-thin, flexible device that enables non-invasive, continuous blood pressure monitoring. This ultra-low power device is designed to be accurate and wireless, making it suitable for patients across all age groups, from newborns to seniors. By providing a pain-free method for blood pressure monitoring, PyrAmes aims to enhance the quality of care offered by healthcare providers, particularly for vulnerable populations such as neonates.
Nexus A.I.
Seed Round in 2020
Nexus A.I. is a software company founded in 2014 and headquartered in Chicago, Illinois. The company specializes in artificial intelligence applications designed for staffing and team building, catering to both external and internal needs. Its software assists organizations in identifying and curating employee skills and experiences to build effective teams, pinpoint skill gaps, enhance staffing efficiency, and align work with specific competencies. Additionally, the platform tracks skill progression and facilitates the organization of teams around project-based work, helping companies achieve optimal utilization rates. Nexus A.I. serves a global clientele, supporting users in over fifty countries across six continents.
Rellevate
Pre Seed Round in 2020
Rellevate, LLC is a financial services company based in Stamford, Connecticut, established in 2019. It specializes in digital banking services designed to enhance consumer financial management. Rellevate offers a range of products, including digital accounts that earn interest, as well as features like Pay Any-Day, bill payment, and money transfer services. These offerings are primarily delivered through employers, aiming to improve employee retention, satisfaction, and loyalty. By allowing users to access, move, and utilize their money anytime and anywhere, Rellevate empowers consumers to take greater control of their finances and fosters a more adaptable financial ecosystem.
Proov
Seed Round in 2020
Proov is a company that specializes in developing rapid response urine test strips for measuring progesterone, a hormone essential for confirming ovulation and supporting conception. Unlike traditional in-home tests that primarily measure hormones like LH, FSH, and estrogen during the early menstrual cycle, Proov's tests provide a more comprehensive assessment by specifically tracking progesterone levels. This capability allows women to not only predict ovulation but also to identify potential hormonal imbalances that may contribute to infertility or miscarriage. By enabling women to monitor their hormonal health at home, Proov offers a cost-effective alternative to fertility clinics and IVF treatments, empowering them to take control of their reproductive health.
Allotrope Medical
Convertible Note in 2020
Allotrope Medical Inc. is a Houston-based medical device company focused on enhancing surgical procedures by developing innovative devices for ureter identification. The company's flagship product, the StimSite, is an intuitive handheld device that aids surgeons in quickly and accurately locating ureters during pelvic surgeries. This device features a simple design with a single button, eliminating the need for complex pre- and post-operative procedures. Founded in 2016, Allotrope Medical aims to improve surgical outcomes by providing tools that streamline the identification and localization of ureters, thus facilitating safer and more efficient operations.
Your Fare
Convertible Note in 2020
Your Fare, Inc., established in 2016 and based in San Francisco, California, specializes in developing an application that enables restaurants to manage all their online orders through a single platform. The company's ordering management system allows restaurateurs to consolidate orders from various sources, replace traditional online ordering tablets, and monitor daily sales via one dashboard. Additionally, Your Fare helps manage third-party delivery services, integrating them into a unified interface. This streamlined approach aims to enhance operational efficiencies and profit margins for restaurants by automating the handling of online meal orders and reducing order delivery time.
Renovion
Series A in 2020
Renovion, Inc. is a clinical-stage pharmaceutical company based in Chapel Hill, North Carolina, focused on developing innovative therapeutics for chronic inflammatory respiratory diseases. The company's primary product, Arina-1, is a nebulized therapy aimed at treating conditions such as cystic fibrosis, severe asthma, chronic obstructive pulmonary disease, and bronchiectasis, particularly in patients who have undergone lung transplantation. Founded in 2013, Renovion was established to capitalize on a pharmaceutical discovery from the University of North Carolina-Chapel Hill, which targets infection and airway inflammation. By addressing the mucus, inflammation, and infection associated with these conditions, Renovion aims to improve the quality of life for patients suffering from chronic respiratory diseases.
VenoStent
Seed Round in 2020
VenoStent, Inc. is a clinical-stage tissue engineering company based in Nashville, Tennessee, with an additional office in Houston, Texas. Founded in 2017, it specializes in the development of bioresorbable smart polymers designed to enhance vascular surgery outcomes. The company’s primary product, SelfWrap, is a perivascular wrap that functions as an external stent, providing mechanical support to veins and promoting outward growth. This innovative technology aims to reduce complications at the vein-artery junction in dialysis patients, particularly by minimizing vein collapse and improving the usability of arteriovenous fistulas (AVF). By utilizing a new class of shape-memory polymers that do not require sutures, VenoStent's approach reduces surgery time and lowers the risk of infection, ultimately enhancing the quality and length of life for patients with chronic kidney disease undergoing hemodialysis.
Mi Padrino
Convertible Note in 2020
Mi Padrino is an event planning service tailored for the Hispanic community, assisting families in organizing, planning, and funding significant cultural celebrations such as Quinceañeras, weddings, and baptisms. Founded by Kim Gamez, who recognized the complexities involved in coordinating these traditional events, Mi Padrino offers an innovative platform that simplifies the process. The service allows users to manage event details and share them with friends and family worldwide, ensuring that loved ones can participate in celebrations regardless of their location. Additionally, the platform facilitates the acceptance of funds from sponsors, making financial contributions more accessible and efficient. Overall, Mi Padrino provides a comprehensive solution for families to honor their traditions while embracing modern technology.
Path Ex
Convertible Note in 2020
Path Ex, Inc. is a Nashville-based company established in 2017 that specializes in the development of extracorporeal blood-cleansing equipment aimed at treating sepsis, a severe and often fatal condition linked to blood-borne infections. The company has created a proprietary technology that selectively separates and captures bacteria and toxins from human blood, offering a novel approach to treatment. Unlike traditional methods that rely on broad-spectrum antibiotics to kill infections, Path Ex's device effectively removes intact bacteria from the bloodstream, regardless of the bacteria type or antibiotic resistance. This innovative technology has the potential to improve patient outcomes by reducing diagnostic times, treatment costs, readmission rates, and fatalities associated with sepsis.
PyrAmes
Convertible Note in 2020
PyrAmes is a healthcare technology company focused on transforming the delivery of medical care through advanced sensor measurement. The company has developed a paper-thin, flexible device that enables non-invasive, continuous blood pressure monitoring. This ultra-low power device is designed to be accurate and wireless, making it suitable for patients across all age groups, from newborns to seniors. By providing a pain-free method for blood pressure monitoring, PyrAmes aims to enhance the quality of care offered by healthcare providers, particularly for vulnerable populations such as neonates.
Machfu
Series A in 2019
Machfu Inc. is a company that specializes in applications and infrastructure for the industrial Internet of Things (IoT), facilitating data, analytics, and visualization for industrial enterprises. Based in Rockville, Maryland, Machfu has developed a smartphone for machines that enhances communication between industrial assets and integrates them with both legacy systems and cloud-based platforms. The company's Mach-IT solution enables seamless communication among various pieces of equipment and information processing systems. Founded in 2015, Machfu aims to simplify the management of industrial IoT environments, providing real-time visibility into operations and equipping operators with the data needed to make informed decisions. This focus on ease of use allows companies to effectively manage their IIoT ecosystems, encompassing hardware, networking, and security.
Kegg
Convertible Note in 2019
Kegg is a fertility tracking device that combines the functions of monitoring vaginal fluid and facilitating pelvic floor exercises. Founded in 2017 and based in San Francisco, California, Kegg utilizes advanced sensing technology to detect changes in cervical fluid, thereby enabling women to identify their fertile window and ovulation up to seven days in advance. This innovative approach provides essential data that enhances the diagnosis, monitoring, and treatment of women's reproductive health, significantly increasing the chances of natural conception. By offering an intuitive and effective solution, Kegg empowers women with the information they need to make informed decisions regarding their fertility.
Osperity
Series B in 2019
Osperity Inc. specializes in developing enterprise visual monitoring solutions aimed at enhancing the management of field operations, assets, and facilities across various industrial sectors, including mining, construction, security, and oil and gas. The company offers a cloud-based platform that utilizes advanced computer vision and integrates data from multiple sensors and systems to detect significant operational events. This platform, known as Osprey Reach, provides stakeholders with visual reports and alerts, enabling them to conduct remote inspections, optimize labor productivity, and enhance operational efficiency and safety. Founded in 2011 and based in Calgary, Canada, Osperity Inc. was previously known as Osprey Informatics Ltd.
Galen Data
Seed Round in 2019
Galen Data, Inc. is a healthcare technology company based in Houston, Texas, founded in 2016. It offers a cloud-based software platform designed for medical devices, enabling them to centralize and securely store data while leveraging cloud technologies. The platform is FDA-compliant and HITRUST-certified, integrating seamlessly with major electronic health record systems. Galen Data provides tools for data visualization and analytics, which help healthcare providers track patient compliance and optimize information management. By maintaining the necessary infrastructure and ensuring compliance with cybersecurity and global regulations, the company allows medical device companies to focus on their core innovations without needing expertise in software design or data management. This approach offers significant time and cost savings, as well as reduced risk in bringing medical devices to market.
Zibrio
Convertible Note in 2019
Zibrio is a balance diagnostics company based in Houston, Texas, that was established in 2017. The company specializes in a technology that utilizes insights from postural control and machine learning to detect subtle changes in balance. Originally developed from NASA technology designed for astronauts returning from space, Zibrio's device aims to empower individuals to take charge of their health. By measuring balance and weight, it helps users understand their balance profiles and offers guidance for improvement. The company's mission is to enhance health outcomes, reduce the risk of falls, and promote overall balance and well-being.
Allotrope Medical
Convertible Note in 2019
Allotrope Medical Inc. is a Houston-based medical device company focused on enhancing surgical procedures by developing innovative devices for ureter identification. The company's flagship product, the StimSite, is an intuitive handheld device that aids surgeons in quickly and accurately locating ureters during pelvic surgeries. This device features a simple design with a single button, eliminating the need for complex pre- and post-operative procedures. Founded in 2016, Allotrope Medical aims to improve surgical outcomes by providing tools that streamline the identification and localization of ureters, thus facilitating safer and more efficient operations.
VenoStent
Pre Seed Round in 2019
VenoStent, Inc. is a clinical-stage tissue engineering company based in Nashville, Tennessee, with an additional office in Houston, Texas. Founded in 2017, it specializes in the development of bioresorbable smart polymers designed to enhance vascular surgery outcomes. The company’s primary product, SelfWrap, is a perivascular wrap that functions as an external stent, providing mechanical support to veins and promoting outward growth. This innovative technology aims to reduce complications at the vein-artery junction in dialysis patients, particularly by minimizing vein collapse and improving the usability of arteriovenous fistulas (AVF). By utilizing a new class of shape-memory polymers that do not require sutures, VenoStent's approach reduces surgery time and lowers the risk of infection, ultimately enhancing the quality and length of life for patients with chronic kidney disease undergoing hemodialysis.
Ictero Medical
Convertible Note in 2019
Ictero Medical is a medical device company focused on developing minimally invasive solutions for gallbladder ablation. The company offers a specialized tool designed to treat high-risk patients suffering from gallstone disease. This innovative treatment can be performed in an interventional radiology suite, requiring only minimal local anesthesia. By defunctionalizing the gallbladder without surgical removal, Ictero Medical enables physicians to provide patients with the advantages of surgical intervention while significantly reducing associated risks.
SIERA.AI
Seed Round in 2019
SIERA.AI specializes in enhancing the productivity and safety of industrial vehicles, such as forklifts and cranes, through its software-as-a-service (SaaS) platform. The company's technology digitizes compliance paperwork, monitors equipment health, and tracks safety violations by utilizing data from AI-enabled sensors. By offering features like a cloud-based inspection checklist and automatic collision prevention, SIERA.AI helps clients across various sectors—including manufacturing, logistics, and government—reduce accidents, improve operational efficiency, and gain insights into their vehicle fleets. The company operates primarily in North America and serves a diverse clientele in industries such as transportation, utilities, and food and beverage.
Ikonopedia
Series C in 2019
Ikonopedia, LLC specializes in developing a cloud-based breast study interpretation and reporting system aimed at enhancing the workflows of radiologists. Established in 2012 and headquartered in Dallas, Texas, the company provides a comprehensive Mammography Reporting System that generates structured, MQSA-compliant reports tailored to individual radiologists, as well as SonoPro, a web application designed to assist radiologists during diagnostic breast ultrasound exams. Ikonopedia's solutions are utilized in telemammography and satellite clinics, featuring capabilities such as automated patient tracking and monitoring to ensure comprehensive care. The system supports patient letters and questionnaires in multiple languages and is designed to be compatible with modern devices. By prioritizing clear and consistent clinical reporting, Ikonopedia aims to enhance patient safety, reduce errors, and ensure compliance with industry standards, ultimately contributing to improved health outcomes for women.
MacroFab
Series A in 2019
MacroFab operates an electronics manufacturing platform that facilitates the custom production of printed circuit board assemblies (PCBAs) through its network of North American factories. The company provides a user-friendly service that simplifies the manufacturing process, allowing businesses of all sizes and stages of product development to efficiently prototype and produce their products. By integrating design data and offering early risk feedback, MacroFab enhances transparency and traceability, which helps teams adapt to rapidly changing market conditions. The platform supports the entire lifecycle of product development, from initial prototyping and engineering to supply chain management, enabling hardware technology companies to bring their products to market quickly and effectively.
TeVido BioDevices
Venture Round in 2019
TeVido BioDevices, Inc. is a biotechnology start-up based in Austin, Texas, focused on developing innovative tissue-engineered products for reconstructive surgery. Founded in 2016, the company utilizes a platform technology that combines 3D bio-printing with a patient's living cells to create custom grafts. These grafts specifically address the needs of individuals who have lost skin color due to scarring or disease, offering improved options for reconstruction. TeVido's technology not only aims to restore lost pigment but also has potential applications in wound healing and cosmetic surgery, ultimately enhancing patient outcomes and quality of life.
ClearCam
Seed Round in 2018
ClearCam Inc. is a medical technology company based in Austin, Texas, founded in 2018. The company specializes in manufacturing a laparoscopic lens cleaner device known as ClearCam Kelling, which is designed to enhance the visual field for surgeons during laparoscopic procedures. This innovative device allows for intra-operative lens cleaning without the need to remove the laparoscope from the body cavity, thereby streamlining surgical processes and improving safety. By eliminating the requirement for additional supplies, ClearCam's technology contributes to reduced procedure time, benefiting patients, surgeons, and surgical staff alike.
TeVido BioDevices
Seed Round in 2018
TeVido BioDevices, Inc. is a biotechnology start-up based in Austin, Texas, focused on developing innovative tissue-engineered products for reconstructive surgery. Founded in 2016, the company utilizes a platform technology that combines 3D bio-printing with a patient's living cells to create custom grafts. These grafts specifically address the needs of individuals who have lost skin color due to scarring or disease, offering improved options for reconstruction. TeVido's technology not only aims to restore lost pigment but also has potential applications in wound healing and cosmetic surgery, ultimately enhancing patient outcomes and quality of life.
Your Fare
Seed Round in 2018
Your Fare, Inc., established in 2016 and based in San Francisco, California, specializes in developing an application that enables restaurants to manage all their online orders through a single platform. The company's ordering management system allows restaurateurs to consolidate orders from various sources, replace traditional online ordering tablets, and monitor daily sales via one dashboard. Additionally, Your Fare helps manage third-party delivery services, integrating them into a unified interface. This streamlined approach aims to enhance operational efficiencies and profit margins for restaurants by automating the handling of online meal orders and reducing order delivery time.
ScribeRule
Seed Round in 2018
software development company specializing in the security, control, and sharing of information and data
Theratome Bio
Series A in 2018
Theratome Bio, Inc. is focused on developing therapeutics derived from the secretome of adult stem cells, with a primary product being Thera-101, an injectable biologic designed for ischemic brain injury, including stroke. The company explores various therapeutic areas such as autoimmune diseases, chronic neurodegenerative disorders, ischemic heart disease, organ transplantation, orthobiologics, peripheral arterial disease, and wound healing. By engaging in the manufacturing, shipping, storage, and application of these cell-free biological drugs, Theratome Bio aims to enhance the healing factors produced by adult human stem cells while minimizing barriers to adoption. Incorporated in 2011 and based in Indianapolis, Indiana, Theratome Bio was previously known as NeuroF.
Riders Share
Seed Round in 2018
Riders Share Inc operates a peer-to-peer motorcycle sharing community that facilitates the rental of street-legal motorcycles through an online marketplace. Founded in 2015 and based in Newport Beach, California, the platform allows motorcycle owners to list their bikes for rent, providing users with a wide selection of options, from low-capacity models to high-end custom rides. With over 2,000 motorcycles available, Riders Share boasts the largest inventory of motorcycle rentals in the United States, serving various major cities including Los Angeles, New York, and Miami. The company employs machine learning to screen and vet riders, ensuring a secure and efficient rental experience, while also offering insurance to protect both renters and bike owners.
Glycos Biotechnologies
Seed Round in 2018
Glycos Biotechnologies, Inc. is a Houston-based company specializing in food science and biotechnology. Founded in 2007, it focuses on developing personalized nutritional foods aimed at addressing dietary deficiencies associated with various health conditions. Its product offerings include Monomega, a pre-digested form of essential omega-3 fatty acids for cell growth; Monomega-V, which enhances the delivery of essential fatty acids along with vitamins; and Peptide Plus, a plant-based protein hydrolysate tailored for individual gut functions. In addition to its nutritional products, Glycos Biotechnologies collaborates with partners in the fuels and chemicals sectors to facilitate the production of high-value products from non-food feedstocks, helping to enhance profitability and reduce carbon footprints. The company works with ethanol and biodiesel businesses, as well as biorefinery operators, to provide integrated solutions for alternative chemicals and fuels production.
PolyPort
Seed Round in 2018
PolyPort Inc. develops encryption software specifically designed for three-dimensional (3D) assets and objects. Founded in 2016 and headquartered in Chamblee, Georgia, the company provides tools that enable designers, engineers, and artists to create prototypes, including automotive mechanisms and architectural designs, while maintaining control over their intellectual property. PolyPort's software allows users to manage and track 3D assets effectively, set usage permissions, and collaborate securely across different platforms without the need for additional hardware or plugins. This approach ensures transparency and efficiency in native workflows, allowing creative professionals to focus on their designs without latency or disruptions.
DNAtrix
Convertible Note in 2016
DNAtrix, Inc. is a clinical-stage biotechnology company based in Texas that specializes in developing virus-driven immunotherapies for cancer treatment. The company’s leading product, DNX-2401, is an oncolytic immunotherapy designed to target and kill glioblastoma cells, a particularly aggressive form of brain cancer. This therapy has shown promising early results, with over 35 patients treated. DNAtrix is also developing additional armed DNX viruses, specifically DNX-2440 and DNX-2450, aimed at treating various solid tumors, as well as MYX-135, which targets hematological malignancies. With a focus on harnessing modified viruses to selectively destroy cancer cells while stimulating the immune system, DNAtrix seeks to expand its platform to address other cancers, including brain metastases, ovarian, and pancreatic cancers. The company was incorporated in 2005 and maintains its headquarters in Houston, Texas, with an additional office in San Diego, California.
Infrastructure Networks
Venture Round in 2016
Infrastructure Networks provides services for the acquisition and delivery of natural energy resources required to power a modern economy. It eliminates the frustrations associated with managing and scaling remote communications by providing end-to-end customer connectivity solutions. By leveraging the global scale and adoption of a leading standards-compliant technology, recognized technology leaders, along with 24/7 monitoring and boots-on-ground service, INET delivers “Wireless Infrastructure-as-a-Service” (W-Iaas) over the industry’s first end-to-end, private, LTE network. The company was founded in 2011 and is based in Houston, Texas.
Materna Medical
Series A in 2016
Materna Medical, Inc. is a medical device company based in Mountain View, California, focused on developing innovative solutions to reduce childbirth-related injuries during vaginal delivery. Incorporated in 2010, the company addresses significant unmet needs in women's pelvic health, operating within a $6 billion market. Materna Medical combines expertise from a diverse team of engineers, scientists, and commercial leaders to transform the standard of care in obstetrics and gynecology. The company's mission centers on empowering women to safeguard their pelvic health through advanced medical technology.
Onit
Venture Round in 2016
Onit, Inc. is a developer of enterprise workflow software and artificial intelligence platforms, primarily focused on enhancing legal and compliance operations within various industries, including technology, insurance, healthcare, and finance. Founded in 2011 and headquartered in Houston, Texas, with additional offices in Austin, New Zealand, and India, the company provides a suite of applications designed to streamline business process automation. Its offerings include Enterprise Legal Management, Matter Management, Legal Spend Management, Contract Lifecycle Management, and Legal Holds, each aimed at improving efficiency and productivity in managing legal operations. Onit's no-code platform allows users to create custom applications without relying on IT support, enabling the automation of typically manual and cumbersome processes. This capability not only helps organizations reduce costs but also facilitates centralized data collection and immediate notifications to relevant parties.
Quad Technologies
Convertible Note in 2016
Quad Technologies is disrupting cell separation and cell therapy workflows by providing researchers with a simple, cell-friendly capture and release technology for cell isolation. Their new MagCloudz™ Streptavidin Cell Separation kit, featuring novel QuickGel™ technology platform, enables straightforward, scalable and fast cell separation with unique magnetic particle dissociation, resulting in complete label free cells. For applications such as T Cell purification, stem cell isolation, circulating tumor cell (CTC) separation and immunotherapy, this unique solution offers drastically improved cell viability, purity and recovery while maintaining a native cellular phenotype.
Dynamo Micropower
Angel Round in 2016
Dynamo Micropower Corporation specializes in developing fuel-flexible gas turbines tailored for small distributed generation applications, primarily in the oil and gas sector. Founded in 2011 and based in Somerville, Massachusetts, the company offers innovative products such as PowerCore, designed for continuous operation in challenging environments, and Infernocore, a flameless turboheater. Dynamo's solutions are engineered to operate using local unrefined gas, significantly reducing energy costs by up to 80% while enhancing power quality by up to 25%, thereby improving the performance of equipment. The company provides a fully packaged, plug-and-play power solution that utilizes flare gas to deliver grid-quality electricity. Dynamo Micropower markets its products through a network of distributors and supports them with a network of service partners. The company has successfully deployed its turbines with notable clients, including Kinder Morgan and Caterpillar.
Adient Medical
Series C in 2016
Adient Medical Inc. is a company specializing in the development and delivery of implantable and absorbable medical devices, primarily focused on preventing pulmonary embolisms. Founded in 2012 and headquartered in Pearland, Texas, Adient Medical aims to create devices that are safe and effective throughout their intended use, and then naturally dissolve without the need for surgical removal. This innovative approach not only enhances patient safety but also reduces the potential for complications and the costs associated with removal procedures. Through its absorbable vascular filter, Adient Medical provides healthcare professionals with a safer alternative for managing the risk of pulmonary embolism in patients.
Autonomous Marine Systems
Seed Round in 2016
Autonomous Marine Systems Inc. is a marine data services company based in Somerville, Massachusetts, founded in 2009. The company specializes in providing customized hydrographic surveys and operates low-cost, self-powered ocean surface drones that form an intelligent sensor network for data collection. Its robotic sailboats, which harness wind and solar energy, are designed for autonomous operation on long-duration missions across vast geographic areas. This technology allows clients in sectors such as defense, energy, shipping, fishing, and research to efficiently gather marine data while minimizing risks to human life and reducing the operational costs associated with traditional vessels in challenging marine environments.
Quad Technologies
Series A in 2015
Quad Technologies is disrupting cell separation and cell therapy workflows by providing researchers with a simple, cell-friendly capture and release technology for cell isolation. Their new MagCloudz™ Streptavidin Cell Separation kit, featuring novel QuickGel™ technology platform, enables straightforward, scalable and fast cell separation with unique magnetic particle dissociation, resulting in complete label free cells. For applications such as T Cell purification, stem cell isolation, circulating tumor cell (CTC) separation and immunotherapy, this unique solution offers drastically improved cell viability, purity and recovery while maintaining a native cellular phenotype.
Adient Medical
Seed Round in 2015
Adient Medical Inc. is a company specializing in the development and delivery of implantable and absorbable medical devices, primarily focused on preventing pulmonary embolisms. Founded in 2012 and headquartered in Pearland, Texas, Adient Medical aims to create devices that are safe and effective throughout their intended use, and then naturally dissolve without the need for surgical removal. This innovative approach not only enhances patient safety but also reduces the potential for complications and the costs associated with removal procedures. Through its absorbable vascular filter, Adient Medical provides healthcare professionals with a safer alternative for managing the risk of pulmonary embolism in patients.
HUVRData
Seed Round in 2015
HUVRData, LLC specializes in developing enterprise asset management software designed to enhance return on investment for asset owners through digital maintenance and inspection workflows. The company's offerings include InspectFlow, a platform for digitizing inspection checklists; ImageFlow, which processes inspection images and allows for tagging and annotating damage; and Anytime / Anywhere Forms, enabling field inspectors to document issues in real-time. Additionally, HUVRData provides a central control panel for asset management, a reporting tool for various formats, and an analytics engine that delivers actionable insights and trend analysis. The firm serves a diverse clientele, including asset owners and service providers in the renewables, oil and gas, maritime, and utility sectors, catering to Fortune 500 companies across multiple industries. Founded in 2014 and based in Austin, Texas, HUVRData focuses on facilitating digital transformation and breaking down data silos within enterprise asset management.
Set.fm
Convertible Note in 2015
Set.fm, Inc. operates an online platform designed for live concert performers, enabling them to capture and sell recordings of their performances immediately after the show. Founded in 2012 and based in Austin, Texas, Set.fm offers a user-friendly mobile application that allows musicians to record audio with or without an interface, facilitating the sale of their live sets directly to fans. This service provides artists with an additional revenue stream while allowing audiences to relive their concert experiences shortly after the event concludes. Formerly known as DejaSet, Inc., the company changed its name in July 2013 and has since become a subsidiary of VNUE, Inc.
Materna Medical
Seed Round in 2014
Materna Medical, Inc. is a medical device company based in Mountain View, California, focused on developing innovative solutions to reduce childbirth-related injuries during vaginal delivery. Incorporated in 2010, the company addresses significant unmet needs in women's pelvic health, operating within a $6 billion market. Materna Medical combines expertise from a diverse team of engineers, scientists, and commercial leaders to transform the standard of care in obstetrics and gynecology. The company's mission centers on empowering women to safeguard their pelvic health through advanced medical technology.
DNAtrix
Series B in 2014
DNAtrix, Inc. is a clinical-stage biotechnology company based in Texas that specializes in developing virus-driven immunotherapies for cancer treatment. The company’s leading product, DNX-2401, is an oncolytic immunotherapy designed to target and kill glioblastoma cells, a particularly aggressive form of brain cancer. This therapy has shown promising early results, with over 35 patients treated. DNAtrix is also developing additional armed DNX viruses, specifically DNX-2440 and DNX-2450, aimed at treating various solid tumors, as well as MYX-135, which targets hematological malignancies. With a focus on harnessing modified viruses to selectively destroy cancer cells while stimulating the immune system, DNAtrix seeks to expand its platform to address other cancers, including brain metastases, ovarian, and pancreatic cancers. The company was incorporated in 2005 and maintains its headquarters in Houston, Texas, with an additional office in San Diego, California.
Wonder Technologies
Seed Round in 2014
Wonder Technologies, Inc. operates a marketplace for consumers to discover and purchase e-gift cards from a variety of national retailers and local specialty stores across the United States. Based in Laguna Beach, California, the company provides a platform that allows users to redeem gift cards at numerous merchants, including coffee shops, restaurants, and spas, by using their credit cards. Through its iOS application, customers can conveniently buy e-gift cards. Additionally, Wonder Technologies offers a card-linked solution designed to streamline the processes of issuing, sending, redeeming, and tracking digital promotions. This innovative approach helps merchants to quickly implement and assess the effectiveness of their marketing initiatives while enhancing customer engagement.
Cerebrotech Medical Systems
Venture Round in 2014
Cerebrotech Medical Systems, Inc. specializes in the development of non-invasive monitoring technology aimed at patients recovering from strokes or traumatic brain injuries. The company's flagship product, the Cerebrotech monitor, is designed to detect early signs of cerebral fluid accumulation, such as edema or bleeding, which are critical indicators in various neurological conditions. By continuously monitoring brain fluids, the device allows healthcare providers to identify potential increases in intracranial pressure before they escalate, enabling timely medical intervention to prevent further brain damage. Founded in 2010 and headquartered in Pleasanton, California, Cerebrotech aims to enhance patient outcomes in neurological assessments and treatment.
Deep Imaging Technologies
Venture Round in 2014
Deep Imaging Technologies, Inc. is a subsurface imaging company established in 2008 and located in Tomball, Texas. The company specializes in developing advanced data collection equipment and software technologies tailored for the oil and gas industry. Its product offerings include surface imaging systems that utilize electromagnetic fields generated at very low frequencies to effectively image geological features. The combination of transmitters, receivers, and imaging software positions Deep Imaging Technologies as a key player in enhancing subsurface data acquisition and interpretation within the sector.
Autonomous Marine Systems
Seed Round in 2014
Autonomous Marine Systems Inc. is a marine data services company based in Somerville, Massachusetts, founded in 2009. The company specializes in providing customized hydrographic surveys and operates low-cost, self-powered ocean surface drones that form an intelligent sensor network for data collection. Its robotic sailboats, which harness wind and solar energy, are designed for autonomous operation on long-duration missions across vast geographic areas. This technology allows clients in sectors such as defense, energy, shipping, fishing, and research to efficiently gather marine data while minimizing risks to human life and reducing the operational costs associated with traditional vessels in challenging marine environments.
TNG Pharmaceuticals
Series A in 2014
TNG Pharmaceuticals, based in Louisville, Kentucky, specializes in the research and development of a veterinary vaccine known as FlyVax, aimed at reducing the horn fly population that affects cattle. Utilizing recombinant protein technology, FlyVax inhibits the horn fly's ability to feed by counteracting its anti-clotting agent, Thrombostasin, thereby provoking an immune response that promotes blood clotting at the site of the wound. Founded in 2011, TNG Pharmaceuticals originated from the University of Louisville's Entrepreneurship MBA program and has gained recognition by winning multiple global business plan competitions.
Payouts Network
Seed Round in 2014
Payouts Network Inc. specializes in customizable, rule-based payout and compensation solutions tailored for the digital landscape. Founded in 2013 and based in Bozeman, Montana, the company offers innovative services such as Instant Payouts and Point of Purchase Payouts. Its enterprise platform supports both B2B and B2C real-time payments, enhancing customer experiences through reduced friction and improved payment controls. Payouts Network serves diverse industries, including customer service, loyalty programs, compensation, and disbursements. The platform also allows businesses to manage digital gift card transactions from various retailers, facilitating near real-time payments to consumers, employees, and other businesses while minimizing costs and fraud.
Quarri
Series C in 2013
Quarri is a provider of web browser information security solutions that focus on securing data at the endpoint. The company's software enables organizations to extend security controls to web browsers accessing their applications, thereby protecting sensitive information from data leakage and hostile websites. Quarri's technology not only safeguards endpoints from malware but also monitors and controls the usage of browser-delivered data. By offering these capabilities, Quarri empowers organizations to leverage web applications while maintaining the privacy and integrity of their sensitive information.
TNG Pharmaceuticals
Seed Round in 2013
TNG Pharmaceuticals, based in Louisville, Kentucky, specializes in the research and development of a veterinary vaccine known as FlyVax, aimed at reducing the horn fly population that affects cattle. Utilizing recombinant protein technology, FlyVax inhibits the horn fly's ability to feed by counteracting its anti-clotting agent, Thrombostasin, thereby provoking an immune response that promotes blood clotting at the site of the wound. Founded in 2011, TNG Pharmaceuticals originated from the University of Louisville's Entrepreneurship MBA program and has gained recognition by winning multiple global business plan competitions.
Cinegif
Seed Round in 2013
Cinegif is a software development company based in Austin, Texas, specializing in a patented video conversion technology that simplifies the creation of animated GIFs. This platform allows marketers and advertisers to transform still images and videos into engaging animated content, facilitating storytelling and communication without the complexities and high costs associated with traditional video. Cinegif's solutions are utilized by branding professionals, email marketing firms, and web hosting companies to enhance customer engagement across various digital channels, including websites, email, social media, text messaging, and digital signage. By providing a user-friendly tool for GIF marketing, Cinegif helps product-based organizations effectively connect with their target audiences.
AdventureLink Travel
Seed Round in 2012
AdventureLink Travel, Inc. is an online booking platform specializing in adventure travel, offering a diverse array of activities such as hiking, scuba diving, culinary experiences, and wildlife safaris across numerous global destinations. Founded in 2006 and headquartered in Altadena, California, AdventureLink aggregates a wide range of tour operators, simplifying the process for consumers and travel agents to research, compare, and book multi-day tours. This innovative platform serves as a comprehensive solution for retail partners, enabling them to introduce and capitalize on the growing market for experiential travel. With an emphasis on scalability, AdventureLink operates on a software as a service model, enhancing booking efficiencies and increasing margins as more partners utilize the system. The company is uniquely positioned within the $130 billion tour industry, catering to the rising demand from travelers seeking memorable and immersive experiences.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at support@teaserclub.com. Your feedback is most welcome.